Share story
Policy

FDA puts Regenxbio's Hunter syndrome gene-therapy trial on hold

Row of Falling Domino Stones Stopped by Red Domino Stone Over Black Background, Risk Management, Intervene or Prevention Concept, 3d Rendering Image: Primary
The FDA placed a clinical hold on REGENXBIO's RGX-121 trial after MRI scans found small nodules or cystic masses in the spines of five of 48 participants in the CAMPSIITE study, according to the company. REGENXBIO said the findings were asymptomatic and investigators considered them nonserious, but it no longer expects to resubmit its biologics license application soon. The agency had rejected the application in February; in June it had said existing data could support an accelerated-approval resubmission.
Sources
BioSpace
Published by Tech & Business, a media brand covering technology and business. This story was sourced from BioSpace and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Products
AI Products

OpenAI discusses $30 billion raise at $1.4 trillion valuation

OpenAI is in talks to raise $30 billion at a $1.4 trillion valuation, Bloomberg reported. The proposed financing would leave investor Tiger Global poised for a $5 billion paper profit on its OpenAI investment, rather than a realiz...

Bloomberg Technology
AI Capital
AI Capital

Arena raises $200 million at $3.1 billion valuation

Arena Intelligence, the startup behind an AI model leaderboard, has raised $200 million at a $3.1 billion valuation, Bloomberg reported. Lightspeed Venture Partners and Khosla Ventures led the financing, with Salesforce Ventures a...

Bloomberg Technology
Capital Infrastructure
Capital Infrastructure

Voltus raises $225 million to expand flexible power capacity

Voltus has raised $225 million in a Series D round to expand a programme that lets large power users pay for electricity capacity gathered from homes and businesses. Generation Investment Management led the round, with Activate Ca...

The Next Web
AI Science
AI Science

Anthropic commits $150 million to AI access for federal research

Anthropic announced a $150 million commitment over three years to the Genesis Mission, a federal initiative that uses AI to accelerate scientific and technological discovery. The company says the funding will make Claude available...

Anthropic Newsroom
Capital Infrastructure
Capital Infrastructure

VEIR raises $110 million for superconducting data centre power systems

VEIR has raised $110 million in a Series C round co-led by Matter Venture Partners and Tyche Partners to expand manufacturing capacity and develop new products. The Massachusetts company makes superconducting power cables for AI d...

The Next Web
AI Science
AI Science

NVIDIA commits $1 billion over five years to US scientific computing

NVIDIA announced commitments valued at $1 billion over the next five years to expand U.S. research capacity in scientific AI and quantum computing. The company made the announcement at a Washington event bringing together U.S. off...

News Releases - NVIDIA Newsroom